Jefferies analyst Chris Howerton upgraded Avadel Pharmaceuticals to Buy from Hold.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on AVDL:
- Avadel Pharmaceuticals to Present at Upcoming Investor Conferences
- Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
- Avadel Stock Rallies after Patent Win against Jazz Pharmaceuticals
- Avadel Pharmaceuticals Announces Favorable Ruling on Motion to Delist REMS Patent from FDA’s Orange Book
- Avadel Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2022 Financial Results